The expression of a winged-helix transcription factor, Foxa2/HNF3b, is essential for development of the node and the notochord. We examined the node/notochord enhancer of mouse Foxa2 for sequence motifs conserved across vertebrate species. We cloned Foxa2 genes from chicken and ®sh, and identi®ed the respective node/notochord enhancers that were active in transgenic mouse embryos. Comparison of the sequences of the enhancers revealed three evolutionally conserved sequence motifs, CS1, CS2 and CS3. Mutational analysis of the mouse enhancer indicated that CS3 is indispensable for gene expression in the node and the notochord, while CS1 and CS2 are required to augment enhancer activity. These motifs do not correspond to the consensus binding sequences of transcription factors known to be involved in node/ notochord development. q
Introduction
The vertebrate body is progressively formed in the rostrocaudal direction during gastrulation. In this process, the organizer plays an essential role in patterning germ layers by expressing morphogenetic signals and antagonists to the signals. The notochord, which is a midline structure derived from the organizer, also plays vital roles in the patterning of surrounding tissues as the source of morphogenetic signals and antagonists. The development of the organizer and its derivatives is controlled by distinct sets of transcription factors expressed in these tissues (reviewed in Camus and Tam, 1999) . In the mouse, the transcription factors expressed in the node (the mouse equivalent of the organizer) include winged-helix transcription factor, Foxa2 (also known as HNF3b), LIM-homeodomain protein, Lhx1 (also known as Lim1), and the homeodomain proteins, Otx2 and Goosecoid. The transcription factors expressed in the notochord include Foxa2 and the T-box protein, Brachyury. The mutant mouse embryos for either one of these genes show various degrees of defects in the node and/or the notochord. The organizer is induced by the synergistic action of Wntlike and activin-like/nodal signals in Xenopus, the chicken and zebra®sh (Joubin and Stern, 1999 ; also, see reviews by Lemaire and Kodjabachian, 1996; Moon and Kimelman, 1998) . In the mouse, the inactivation of Wnt3 or nodal genes causes defects in node development and gastrulation (Conlon et al., 1994; Liu et al., 1999) . Thus, a set of transcription factors must be activated in response to these and other signaling systems for the node. Less is known about gene regulation in the notochord.
To address the mechanism of gene expression in the node and notochord, we analyzed cis-regulatory elements of the mouse Foxa2 gene, which is a key player in the development of these tissues. The mouse embryos homozygous for Foxa2 mutation lack the node and notochord and display severe defects in the dorso-ventral patterning of the embryos (Ang and Rossant, 1994; Weinstein et al., 1994) . Foxa2 is also expressed in the¯oor plate of the neural tube, which is an important tissue for dorso-ventral patterning of the neural tube, and functions as a regulator of¯oor plate development Hogan, 1993, 1994) . We have identi®ed two enhancers for mouse Foxa2. The enhancer for node/notochord expression is located upstream, while the¯oor plate enhancer is located downstream of the transcription unit. The¯oor plate enhancer also drives gene expression in the posterior notochord and posterior gut epithelium ( Fig.  2A ; Sasaki and Hogan, 1996) . Analyses of the¯oor plate www.elsevier.com/locate/modo enhancer revealed that it is directly activated by the Sonic hedgehog signal emanating from the notochord via Gli zinc®nger transcription factors (Sasaki et al., , 1999 .
In this paper, we analyzed the node/notochord enhancer of the mouse Foxa2 gene in detail. To identify the functionally important sequences within the enhancer, we compared the sequences of the node/notochord enhancers of different species. We cloned Foxa2 genes from the chicken and dwarf gourami (Colisa lalia), a ®sh with a compact genome comparable to the puffer ®sh (N. Takahashi, personal communication) . We identi®ed the enhancers of chicken and ®sh Foxa2 genes in transgenic mouse embryos.
Comparison of the nucleotide sequences of the node/notochord enhancers from the three species identi®ed three evolutionally conserved sequence motifs (CS), CS1, CS2 and CS3. The deletion of individual motifs from the mouse enhancer revealed that the CS3 is indispensable for enhancer activity, while the other two are required to achieve a strong enhancer activity. The sequences of these motifs are different from those of the binding sites of the transcription factors previously implicated in development of organizer and/or notochord. The results suggest that transcription factor(s) that have not been registered in node/ notochord development bind to CS3 and regulate the Foxa2 gene in these tissues.
Results

Cloning of Foxa2 genomic clones from chicken and dwarf gourami
We previously identi®ed a node/notochord enhancer of the mouse Foxa2 gene as a 1.5 kb DNA fragment located 215 kb upstream of the transcription initiation site (mNE; see Fig. 2A ; Sasaki and Hogan, 1996) . In understanding the regulation of the enhancer, it is helpful to de®ne DNA sequences that are important for the enhancer activity. Our initial attempt to de®ne such sequences as enhancer subdomains was not successful, because the enhancer activity became too weak when the enhancer was divided into small pieces. Previous studies on Hox and other genes demonstrated that important regulatory sequences are often conserved among different vertebrate species (Hardison, 2000; Nonchev et al., 1996; Popperl et al., 1995; Song et al., 1996) . We thus isolated node/notochord enhancers from chicken and dwarf gourami (Colisa lalia) to compare with the mouse enhancer sequence.
We isolated genomic clones of Foxa2 from chicken and dwarf gourami by screening respective genomic libraries with a mouse Foxa2 (mFoxa2) cDNA as a probe (Sasaki and Hogan, 1993) . The mouse Foxa2 gene consists of two coding exons and three alternative non-coding leading exons that are differentially used depending on the developmental stages and/or the tissues (Sasaki and Hogan, 1994;  Fig. 2A ). Sequence determination of the genomic clones identi®ed positions of putative exons for protein coding regions of Foxa2 genes of the chicken and dwarf gourami, but the possibility of non-coding exons occurring could not be con®rmed ( Fig. 2A) . The position of the intron within the coding region was conserved among Foxa2 genes of the mouse, chicken and dwarf gourami (Fig. 1) . The nucleotide sequence of the chicken clone matched the partial cDNA of chicken Foxa2 in the coding region (Ruiz i Altaba et al., 1995) . The chicken Foxa2 (cFoxa2) amino acid sequence deduced from the genomic sequence is 444 amino acids (a.a.) long and is 77% identical to mFoxa2. The dwarf gourami Foxa2 (dgFoxa2) is estimated to be 415 a.a. long and 66 and 72% identical to mouse and chicken Foxa2, respectively. The protein has 88% identity with zebra®sh Foxa2/Axial (zfFoxa2) at the protein level (Strahle et al., 1993) . Both chicken and dwarf gourami genes show a higher homology with mFoxa2 compared with other mouse Foxa genes, con®rming the homologue relationship. cFoxa2 protein has a 6 a.a. extension at its N-terminus, which is also found for the embryonic form of mFoxa2. The dgFoxa2 protein has one more amino acid extension than zfFoxa2 (Fig. 1 ).
Identi®cation of enhancers for chicken and ®sh Foxa2
In the case of mFoxa2, the node/notochord and¯oor plate enhancers are located in regions around 215 and 18 kb from the transcription start site, respectively ( Fig. 2A ; Sasaki and Hogan, 1996) . We speculated that enhancers of other species might also be located in analogous positions, and thus, cloned the¯anking regions by genomic walking (216.5 to 124 kb of cFoxa2, and 225 to 110 kb of dgFoxa2; Fig. 2A ). We divided these clones into several pieces and assessed them for their enhancer activities. The DNA fragments were placed upstream of a reporter cassette consisting of mouse hsp68 promoter and lacZ-encoding sequence (Sasaki and Hogan, 1996) . The resulting constructs were injected into fertilized mouse eggs and the expression of the lacZ reporter gene in transgenic embryo was examined.
We examined the enhancer activities of two DNA fragments for cFoxa2 ( Fig. 2A ; Table 1 ). One of them, a 2.5 kb fragment (c1), spanning from 26 to 23.5 kb, had a node enhancer activity, which also showed weak activity in the notochord (Table 1) . Thirty-one percent of transgenic embryos (n 13) showed lacZ expression within the node at gestation day 8.0 (E8.0)±E8.5 (Fig. 2B) . The mouse node consists of two germ layers: a dorsal layer that is continuous with the ectoderm, and a ventral layer that is continuous with the endoderm and the notochord (also called the notoplate; Fig. 2C ). At this stage, endogenous Foxa2 is expressed in the node, notochord,¯oor plate and endoderm. The expression in the node is throughout the ventral layer and in the midline of the dorsal layer, which is continuous with the expression in the notochord and the¯oor plate, respectively (Ang et al., 1993; Sasaki and Hogan, 1993; Yasui et al. 1997; Y.N., Y. Fujitsuka and H.S., unpublished observation) . In the c1 fragment, lacZ expression in the node occurred mostly in the ventral layer (Fig. 2C) , although a small number of cells in the dorsal layer also expressed lacZ (data not shown). The ventral layerrestricted activity was also observed with the mouse mNE enhancer (Fig. 2D) . However, the activity of the chicken enhancer was signi®cantly weaker than mNE in the transgenic mouse embryos. The other DNA fragment, 13.5 kb long (c2), which is located downstream of the transcription unit (210.5 to 224 kb), displayed enhancer activities in other tissues and partially resembles the mouse¯oor plate enhancer ( Fig. 2A ; Table 1 ). Fragment c2 showed enhancer activity in the¯oor plate of the neural tube, notochord and the entire gut epithelium, including the liver primordium, in E9.0 embryos (Fig. 2E±G ). This expression pattern reproduced the expression pattern of endogenous Foxa2 at this stage. The strength of this enhancer in the¯oor plate is comparable with that of the mouse¯oor plate enhancer.
We analyzed the enhancer activities of three DNA fragments for dgFoxa2 ( Fig. 2A ; Table 1 ), and all fragments showed distinct enhancer activities. The transgenic embryos with the middle 3 kb fragment (dg2; 28 to 25 kb) expressed lacZ in the node and weakly in the notochord at E8.0 (Fig. 2H ). The expression in the node was primarily in the ventral layer, as observed with c1 and mNE (Fig. 2I) . The expression level of the LacZ gene by this ®sh enhancer is clearly weaker compared with mNE, as judged by the staining for b-galactosidase activity in transgenic mouse embryos. The most upstream fragment (dg1; 224 to 28 kb) had a very weak enhancer activity which drove gene expression in the notochord and the somites at E9.0 (Fig.  2J ,K). The expression in the somites does not correspond to the endogenous gene expression, thus this expression is ectopic. The fragment proximal to the transcription start site (dg3; 25 to 11 kb) had an enhancer activity in thē oor plate and the endoderm at E9.0 (Fig. 2L ,M).
To analyze the activity of dg2 in more detail, we produced two transgenic mouse lines (#18, #20). The initial analysis at E7.5 revealed stronger lacZ expression in line #18 than line #20, and therefore, we used the former line for the analysis. The lacZ expression was initiated as early as E6.5 before node formation. Strong expression was observed in the epiblast at the anterior end of the primitive streak and in the gastrulating axial mesoderm, which matches the expression of Foxa2 (Fig. 2N ). Weak expression of lacZ was also observed in the epiblast at the position of the entire primitive streak, which was not observed for Foxa2 (Fig. 2N ). At E7.5, expression in the node was strong, while expression in the notochord and around the primitive streak was weaker (Fig. 2O) . At E9.0, lacZ was expressed in the notochord and in the posterior region of the embryos (Fig. 2P ). The expression patterns of lacZ transgene at E7.5 and E9.0 were almost identical to those observed with mNE (Sasaki and Hogan, 1996) , except that the expression was stronger in the node than in the notochord. Fig. 1 . Comparison of amino acid sequences of mouse, chicken, dwarf gourami and zebra®sh Foxa2 deduced from respective genomic sequences. Shaded residues are conserved in more than three species. The fork head domain is underlined. Position of an intron (triangles) is well conserved between mouse, chicken and dwarf gourami. The amino acid sequences of mouse and zebra®sh Foxa2 (Axial) are from Sasaki and Hogan (1994) and Strahle et al. (1993) , respectively. The DDBJ accession numbers for the nucleotide sequences straddling the coding regions of cFoxa2 and dgFoxa2 were AB050938 (®rst coding region) and AB050939 (second coding region), and AB050937, respectively.
Identi®cation of three evolutionally conserved sequences in the node/notochord enhancer
To identify sequence motifs conserved among these three species, we compared the sequences of 1.5 kb mouse node/ notochord enhancer (mNE), 2.5 kb chicken node/notochord enhancer (c1) and 2.5 kb dwarf gourami node/notochord enhancer (dg2). Three short sequence motifs were recog-nized that are common to these three enhancer sequences. These are called CS 1 (18 bp), CS2 (17 bp) and CS3 (14 bp) from the 5 H side (Fig. 3A) . The homologies of the CS motifs between the species vary between 59 and 94%, as shown in Fig. 3B . The order of the CSs within the enhancer was also conserved, except that the direction of CS3 was reversed in chicken. The nucleotide sequences of these motifs do not resemble the binding site sequences of the transcription factors known to be involved in the regulation of organizer and/or notochord speci®c genes.
The 3
H portion determines the tissue speci®city while the 5 H portion enhances the activity in the mNE
We showed earlier that a 3 H sub-fragment of 500 bp (fragment B in Fig. 4A ) of mNE including CS3 has a weak node/ notochord enhancer activity (Sasaki and Hogan, 1996) . We also tested the activity of a 1 kb long 5 H fragment of mNE (fragment A in Fig. 4A ) containing CS1 and CS2 in transgenic mouse embryos. No transgenic embryos (n 10) expressed lacZ in the node or the notochord. Instead, 60% of transgenic embryos weakly expressed lacZ in the paraxial mesoderm and endoderm ( Fig. 4D ; Table 1 ). Therefore, this 5 H region of mNE itself does not have an activity for gene expression in the node/notochord, but has a weak activity to drive gene expression in the paraxial mesoderm and endoderm. Consistent with the previous results, fragment B containing CS3 had a weak enhancer activity in the node and notochord gene expression (Fig. 4E) . Forty-six percent of transgenic embryos (n 13) showed gene expression in the node and the notochord. This expression rate is lower than that of full-length mNE (82%, n 11), and the expression level of lacZ, as judged by staining for b-galactosidase activity, is also lower than mNE. The expression pattern of lacZ is also different. With fragment B, the expression in the node is less conspicuous than that of mNE. In addition, the ectopic expression around the primitive streak and in the posterior mesoderm and endoderm observed with fulllength mNE did not occur (compare Fig. 4C and Fig. 4E ). Thus, fragment B contains a key sequence to activate genes in the node and notochord, but this fragment alone is not suf®cient to achieve full enhancer activity. Taken together, the mNE consists of two functional domains: the 3 H domain 
a DNA, DNA fragment analyzed; Tg, number of transgenic embryos identi®ed by PCR analysis of yolk sac DNA; lacZ, number of embryos in which staining for b-galactosidase activities was observed; midline, number of embryos in which staining for b-galactosidase activities was observed in the midline structures, i.e. node, notochord or¯oor plate.
b Expression levels of b-galactosidase in the node, notochord (nc), primitive streak/paraxial mesoderm and endoderm (ps/pm),¯oor plate (fp), liver primordium (lp), gut epithelium (gut), and other tissues (other) are indicated by positive (1), very faint (^) or negative (2). c E8 and E9 indicate embryos of E8.0±8.5 and E9.0±9.5, respectively. from the translation initiation site for chicken and dwarf gourami genes and that from the transcription start site for the L1 transcript for the mouse gene (Sasaki and Hogan, 1994) . Horizontal lines below the maps indicate the DNA fragments tested for enhancer activities. Two enhancers for the mouse gene (marked by asterisks) were previously identi®ed by Sasaki and Hogan (1996) . mNE, the mouse node/notochord enhancer. The fragments indicated by thick lines (mNE, c1 and dg2) contain node/notochord enhancer activities. (fragment B), which confers node/notochord speci®city of the gene expression, and the 5 H domain (fragment A), which is not speci®c to the node/notochord by itself, but supports strong gene expression in synergy with the 3 H domain.
2.5. CS3 is essential for node/notochord speci®c gene expression, while CS1 and CS2 are required for strong enhancer activity
To clarify the role of individual CS motifs in the enhancer, we introduced deletions of individual motifs in mNE, and tested the activities of the mutated enhancers in transgenic mouse embryos ( Fig. 4; Table 2 ). When the CS3 sequence was deleted from mNE (DCS3), no transgenic embryos (n 10) showed gene expression in the node or the notochord ( Fig. 4H; Table 2 ). Therefore, CS3 is an essential element for the enhancer activity in the node/notochord. We also examined the activity of another deletion mutant of the enhancer, named DCS3
H , which has a 15 bp deletion including the 3 H half of CS3 (Fig. 4B) . No transgenic embryo (n 5) bearing the DCS3 H enhancer showed transgene expression in the node or the notochord ( Fig. 4I ; Table 2 ). These results suggest that the 3 H portion of CS3, which is deleted in both DCS3 and DCS3 H , is especially important for the enhancer activity. The sequence of the CS3 motif does not match the binding sites of the transcription factors already suggested to be involved in node/notochord gene expression. It was also noted that mesodermal and endodermal expression around the primitive streak and/ or paraxial region was also affected in DCS3 and DCS3
H . With DCS3 and DCS3 H , transgene expression in the primitive streak and paraxial region was lost in 50 and 40% of transgenic embryos, respectively (Table 2 ). In the remaining 50 and 60% of these embryos with DCS3 and DCS3 H enhancers, the expression patterns were modi®ed, in that the transgene-expressing cells were scattered in the paraxial endoderm or con®ned to the medio-lateral portion of the posterior endoderm, respectively ( Fig. 4H,I ; Table 2 ). In contrast, expression with the wild type enhancer is stronger and more uniform in the mesoderm and endoderm of the primitive streak and the posterior paraxial region (Fig. 4C) .
In contrast to the essential role of CS3, CS1 and CS2 were dispensable for gene expression in the node/notochord. However, deletion of either CS1 or CS2 reduced the enhancer activity. It was most clearly seen as changes in the gene expression pattern (Fig. 4F,G) . With the DCS1 or DCS2 enhancer, gene expression in the medial portion of the node was weaker than in the rim, while the expression in the node was uniform with the wild type enhancer. With DCS1 or DCS2, mesodermal and endodermal expression around the primitive streak and paraxial region was also clearly decreased. In addition to the change in gene expres- sion patterns, there was a tendency of reduction in the frequencies of gene expression with DCS1 or DCS2. With the wild type mNE, 82% of transgenic embryos (n 11) showed clear lacZ expression in the node/notochord at E8.0±9.0. In contrast, with DCS1 or DCS2 enhancers, 50 (n 6) and 57% (n 7) of transgenic embryos showed lacZ expression in the node/notochord, respectively (Table  2) . Thus, CS1 and CS2 sequences appear to be required for strong enhancer activity.
Discussion
Organization of the mNE
The mNE consists of two functionally separable regions.
The 3
H portion of the enhancer (fragment B) is suf®cient for the tissue speci®city of gene expression. The 5 H portion of the enhancer (fragment A), which alone, does not drive gene expression in the node/notochord, is required for strong enhancer activity ( Fig. 4; Table 2 ). Fragment A by itself weakly activates gene expression in the paraxial mesoderm and endoderm, suggesting that it contains binding sites for transcription factors commonly used for gene expression in mesodermal and endodermal cells. These transcription factors may also be used to achieve strong gene expression in the node/notochord, in combination with the transcription factors that bind to fragment B.
DCS3/3
H not only eliminated the gene expression in the 
a DNA, DNA fragment analyzed; Tg, number of transgenic embryos identi®ed by PCR analysis of yolk sac; lacZ, number of embryos in which staining for b-galactosidase activities was observed.
b The cases of b-galactosidase expression in the node/notochord and in the primitive streak, paraxial mesoderm and/or endoderm are also indicated. node/notochord, but also modi®ed the pattern of gene expression of mesoderm and endoderm around the primitive streak and in paraxial regions (Fig. 4) . This result also suggests the involvement of common transcription factors for gene expression in the node/notochord and in other mesodermal and endodermal cells. Thus, the enhancer consists of the domain for node/notochord speci®city determination and the domain for augmentation of the enhancer activity, the latter being active also in the paraxial mesoderm and endoderm, and these domains act synergistically to achieve strong gene expression in the node/notochord (Fig. 5) . Deletion analysis demonstrated the importance of CS1/2/3. The motif of CS3 is required for node/notochord speci®c gene expression, while the motifs of CS1 and CS2 are required for strong enhancer activity. Therefore, CS3 and CS1/2 are key sequences of speci®city determination and augmentation regions, respectively (Fig. 5) .
Identi®cation of novel enhancer sequences involved in node/notochord gene expression
How are the conserved sequence motifs of the node/notochord enhancer related to the current knowledge of node/ notochord development? Previous studies have revealed the signals and their downstream effector molecules involved in organizer formation. The synergistic action of Wnt-like and activin-like/nodal signals induces the expression of organizer speci®c genes at the dorsal side of an embryo (see reviews by Lemaire and Kodjabachian, 1996; Moon and Kimelman, 1998) . The downstream effector of the Wntlike signal is a Tcf/Lef transcriptional regulator (Behrens et al., 1996; Molenaar et al., 1996) . Tcf/Lef induces a homeodomain transcription factor, Siamois/Twin of Xenopus (the mouse homologue of which has not yet been identi®ed) at the dorsal region, and thus, Siamois/Twin activates organizer speci®c genes (Brannon et al., 1997; Brannon and Kimelman, 1996; Laurent et al., 1997) . The downstream transcription factors of the activin-like/nodal signal are a winged-helix protein, FoxH1/FAST1, and Mix-related homeodomain proteins. These proteins directly activate the organizer speci®c genes (Chen et al., 1996; Germain et al., 2000; Labbe et al., 1998) . Apparently, sequences of CS1/2/3 identi®ed in the node/notochord enhancer of the Foxa2 gene are different from consensus recognition sequences of these transcription factors.
The transcription factors known to be involved in notochord development are Foxa2, a T-box protein, Brachyury, and a homeodomain protein, Xnot/¯h, of Xenopus and zebra®sh (the mouse homologue of which has not yet been identi®ed). Genetic analysis in mice revealed that the LIM-homeodomain protein, Lhx1, is required for the expression of Foxa2 in the anterior notochord (Shawlot and Behringer, 1995) . Foxa2 also has an auto-activation mechanism (Pani et al., 1992; Sasaki and Hogan, 1994) . However, the sequences of CS1/2/3 are clearly different from the binding sites of Foxa2 or Brachyury. It is not likely that CS1/2/3 are the target sites of Lhx1 or a¯h homologue, since CS motifs do not contain the core recognition sequences of homeodomain proteins, ATTA. Consistent with this notion, GST fusion proteins of the DNA binding domains of Brachyury, Xlim1 or Xnot1 did not show speci®c binding to the CS3 sequence in gel mobility shift assays (Y.N. and H.S., unpublished observations).
The mechanisms of gene expression in the notochord were analyzed well in lower chordates, the two ascidian species, Ciona intestinalis and Halocynthia roretzi. Ascidian homologues of Brachyury, Ci-Bra and As-T are speci®cally expressed in the notochord of these two species. The promoter of Ci-Bra is activated in the notochord by Suppressor of Hairless (Su(H)) and repressed by Snail transcription factors, respectively (Corbo et al., 1997 Fujiwara et al., 1998) . On the other hand, the As-T promoter is shown to be regulated by As-T itself and by an unidenti®ed transcription factor (Takahashi et al., 1999) . It is an open question whether similar mechanisms operate in gene expression in the mammalian notochord. In any case, the CS1/2/3 are also different from the binding sites of these transcription factors.
Taken together, the sequences of the CS1/2/3 are not the target sequences of the transcription factors previously identi®ed as regulators of node and/or notochord development. This fact suggests that novel transcription factors activating CS1/2/3 are involved in node/notochord development. It is likely that there are parallel mechanisms for node/notochord gene expression, and that these mechanisms operate in a synergistic manner to achieve strong gene expression and/ or tight regulation of gene expression. Since CS3 is conserved among three evolutionally divergent species, the novel mechanism involved in CS3 activation should be commonly used in the vertebrate species. However, the mechanism by which the CS3 motif regulates gene expression in the node/notochord is still unknown, since CS3 by itself is not suf®cient to drive gene expression in the node/ notochord in transgenic mouse embryos (Y.N. and H.S., unpublished observation). Identi®cation of the CS3 binding protein(s) should reveal a new aspect of the regulation of node/notochord development. H portion of the enhancer containing CS3 has an enhancer activity in the node and notochord, and the CS3 motif is an essential element. The 5 H portion containing CS1 and CS2 does not have a speci®city to node/notochord, but is required for strong enhancer activity of mNE.
Experimental procedures
Isolation of genomic clones for chicken and dwarf gourami Foxa2
Using a full length Foxa 2/Hnf3b cDNA of the mouse (Sasaki and Hogan, 1994) as a probe, we screened 6 £ 10 5 pfu of a lEMBL3 SP6/T7 chicken genomic library (CLON-TECH) and 3.6 £ 10 5 pfu of a lEMBL3 dwarf gourami genomic library (a gift from N. Takahashi) under a lowstringency condition as described previously (Sasaki and Hogan, 1993) . The conditions of ®nal washes were 0.2£ SSC, 0.5% SDS at 378C for chicken, and 0.5£ SSC, 0.5% SDS at 608C for the dwarf gourami library. Five and 20 positive clones for chicken and dwarf gourami, respectively, were obtained. Representative clones, chicken c5 and dwarf gourami dg10, were subcloned into Bluescript II (Stratagene) and sequences encompassing the coding regions were determined using an ABI 373A sequencer (Applied Biosystems). To walk along the chicken genome, we screened a lFix genomic library (a gift from Y. Kamachi) using either end of c5 as probes. Two overlapping 5 H extended clones, cE1 and cB5, and one 3 H extended clone, cB1, were obtained. Re-screening of the dwarf gourami library with either end of dg10 identi®ed a 5 H extended clone, dg2-6, and a 3 H extended clone, dg6.
Construction of transgenes
For the constructs listed in Fig. 2 , fragments isolated from chicken or dwarf gourami Foxa2 genomic clones were blunt-ended and cloned into the SmaI site of the ASShsplacZpA vector (Sasaki and Hogan, 1996) after ligation of a SmaI±NruI linker. For the constructs listed in Fig. 4 , we ®rst introduced deletions of CS1, CS2 or CS3 into the mNE fragment using an ExSite PCR-based site-directed mutagenesis kit (Stratagene) using Pfu DNA polymerase (Strategene) in place of Taq DNA polymerase to minimize PCRassociated mutations. After con®rmation of the entire DNA sequence, the mutated enhancer fragments were cloned into the ASShsplacZpA vector.
Analysis of enhancer sequences
The nucleotide sequences of mNE, c1 and dg2 were determined using an ABI 373A sequencer (Applied Biosystems) by the subcloning of DNA fragments and primer walking. CS1/2/3 were identi®ed using the MacVector program as common sequence motifs to these enhancers. The TFSEARCH program (http://www.rwcp.or.jp/papia/) did not identify strong candidates of transcription factors that bind to the CS1/2/3.
Production of transgenic embryos
Transgene DNAs were puri®ed by a gelase (Epicentre Technologies) method . Transgene DNA (2±3 ng/ml) was injected into the pronuclei of (C57BL6 £ C3H)F2 fertilized eggs as described . Integration of the transgene in the embryo genome was determined by PCR ampli®cation of the lacZ sequence from genomic DNA extracted from yolk sac DNA. The preparation of yolk sac DNA and sequences of primers have been previously described .
4.5. b -Galactosidase staining of transgenic embryos b-Galactosidase activities in dissected embryos were detected following a standard protocol . The reaction time for color development was between 15 min and overnight at 378C, depending on the strength of enzyme activities. The stained embryos were photographed either in PBS or in 80% glycerol in PBS-T; they were then sectioned according to Gossler and Zachgo (1993) .
